Stifel Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Stifel Financial’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-154	Closed	-$97K	–	2741
2017 Q3	$97K	Hold	154	–	–	﹤0.01%	2474
2017 Q2	$74K	Buy	154 +3	+2%	+$1.83K	﹤0.01%	2475
2017 Q1	$113K	Buy	151 +2	+1%	+$1.79K	﹤0.01%	2415
2016 Q4	$144K	Sell	149 -1	-0.7%	-$1.14K	﹤0.01%	2321
2016 Q3	$201K	Sell	150 -15	-9%	-$16.9K	﹤0.01%	2183
2016 Q2	$144K	Buy	+165	New	+$219K	﹤0.01%	2330
2016 Q1	–	Sell	-165	Closed	-$305K	–	2407
2015 Q4	$305K	Buy	165 +6	+4%	+$12K	﹤0.01%	1906
2015 Q3	$311K	Buy	+159	New	+$372K	﹤0.01%	1809

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Stifel Financial's TCON Position: Q4 2017 in Review

Stifel Financial sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2017, closing a stake of 154 shares — an estimated $97K sold.

Stifel Financial first reported a position in TCON in Q3 2015 and held it in 8 quarters. The position peaked at $311K in Q3 2015. 32 funds tracked by Wall St. Rank hold TCON as of Q4 2017.

Stifel Financial reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Stifel Financial sold 154 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2017, an estimated $97K.
Stifel Financial first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 8 quarters.
Stifel Financial's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $311K in Q3 2015.
32 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2017.

Based on Stifel Financial's 13F filing for Q4 2017, filed 14 Feb 2018.